Pharmaceuticals

Global Inflammatory Bowel Disease Market 2015-2019

  • TEC221010
  • 146 Pages
  • April 2015
  • Pharmaceuticals

About Inflammatory Bowel Disease

Inflammatory bowel disease is a condition includes a group of autoimmune diseases such as Crohn's disease and ulcerative colitis. It causes chronic inflammation of a specific part or the entire GI tract. Both Crohn's disease and ulcerative colitis include symptoms such as severe persistent diarrhea, abdominal cramps and pain, rectal bleeding, fatigue, and weight loss. Inflammatory bowel disease can also prove to be life-threatening for the patients. Ulcerative colitis generally affects the colon, where inflammation and ulcers develop in the innermost lining of the colon and the rectum of a patient. Crohn's disease causes inflammation of the lining of the GI tract. The inflammation in Crohn's disease affects various areas of the GI tract such as the large intestine and small intestine, or both. Inflammatory bowel disease is a chronic medical condition, which has no permanent cure and demands a lifetime of treatment and management.  The preferred treatment options include anti-inflammatory steroidal products and immuno-suppressive agents such as the TNF-α inhibitors.



TechNavio's analysts forecast the Global Inflammatory Bowel Disease market to grow at a CAGR of 3.95 percent over the period 2014-2019.



Covered in this Report

This report covers the present scenario and the growth prospects of the Global Inflammatory Bowel Disease market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of inflammatory bowel disease. The market includes data from the sales of various drusg which are used for the treatment of Crohn's Disease and Ulcerative Colitis.



On the basis of the functioning of the drugs used for treatment, the Global Inflammatory Bowel Disease market is categorized into three segments.



• 5-ASA

• Antibiotics

• Immunomodulators

On the basis of the type of molecule used for treatment, the Global Inflammatory Bowel Disease market is categorized into two segments.



• Biologics

• Small Molecules

On the basis of route of administration adopted for the treatment, the Global Inflammatory Bowel Disease market is categorized into two segments.

• Oral

• Parenteral



On the basis of the form of drug used to treat the disease, the Global Inflammatory Bowel Disease market is categorized into two segments.



• Solid

• Liquid

The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the Global Inflammatory Bowel Disease market. The vendor landscape includes an analysis of the major vendors, along with the competitive performances of their portfolios. In addition, the report discusses the major drivers, challenges and trends influencing the market. In addition, late-stage pipeline molecules developed for the treatment of inflammatory bowel disease are discussed.



TechNavio's report, Global Inflammatory Bowel Disease Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the landscape of the Global Inflammatory Bowel Disease market and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.



Key Regions

• Americas

• APAC

• EMEA    

   

Key Vendors

• Abbvie

• Biogen Idec

• Janssen Pharmaceuticals

• Merck & Company

• Shire

• UCB 



Other Prominent Vendors

 • Amgen

• Akebia Therapeutics

• Boehringer Ingelheim

• Celltrion

• ChemoCentryx

• Ferring Pharmaceuticals

• Galapagos

• Genentech

• Merck

• Mitsubishi Tanabe

• Novartis

• Novo Nordisk

• Pfizer

• Salix Pharmaceuticals



Market Driver

• Increase in Instances of Inflammatory Bowel Disease

• For a full, detailed list, view our report



Market Challenge

• High Cost of Drugs

• For a full, detailed list, view our report



Market Trend

• Dominance of Market by Biologics

• For a full, detailed list, view our report



Key Questions Answered in this Report

• What will the market size be in 2019 and what will the growth rate be?

• What are the key market trends?

• What is driving this market?

• What are the challenges to market growth?

• Who are the key vendors in this market space?

• What are the market opportunities and threats faced by the key vendors?

• What are the strengths and weaknesses of the key vendors?


Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global Dialysis Market (Types, Products and Services, End-users and Geography)Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Dialysis is the process of removing excess water and waste from the blood by artificial means, primarily in cases of renal failure. It is also used for patients with acute ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Hemophilia Treatment Market (Type, Medicine and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Hemophilia is a hereditary genetic disorder which impairs body ability to control coagulation or blood clotting. In this disease, clotting factors control bleeding from a broken vessel is deficient; therefore, ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Atrial Fibrillation Market (Treatment Type, Geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast (2013-2020)

Atrial fibrillation (AF) is a type of arrhythmia which is characterized by poor blood flow in the body due to an irregular and rapid heart rate. The geriatric population is ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Asia-Pacific Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Opportunities and Forecasts, 2014 - 2020

Asia-Pacific Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Opportunities and Forecasts, 2014 - 2020

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

Hormone Refractory Breast Cancer Asia-Pacific Market Research Report, 2013 - 2020

Breast cancer is the most common type of malignant cancer prevalent in women above the age of 40. According to the estimates of World Health Organization, cancer is the most ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

Global Incretin-Based Drugs Market (Drug Type, Formulation and Geography) - Size, Share, Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2014 - 2020

Incretins are gut derived hormones, released after the ingestion of food. Incretins are classified into glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP). Both the molecules are inactivated by enzyme ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>